Taking Mounjaro when you have flu: what the evidence says

Why flu and tirzepatide can clash

Mounjaro (tirzepatide) slows the rate at which the stomach empties its contents. In ordinary circumstances that is part of how it reduces appetite. When you have flu, your stomach is often already irritated — nausea, loss of appetite and sometimes vomiting come with the territory of a systemic infection. Layering a medicine that already slows gastric motility on top of an inflamed, unsettled gut can amplify those symptoms considerably.

The NHS tirzepatide medicines page notes that nausea, vomiting and diarrhoea are among the most common side effects of treatment. During flu, any of those can tip from manageable to severe more quickly than usual. That matters beyond mere discomfort: repeated vomiting or diarrhoea while on a GLP-1 medicine significantly increases your risk of dehydration, and dehydration in turn can stress your kidneys.

A question our prescribers hear most weeks is whether one missed or delayed dose during illness will undo progress. The honest answer is no, a single delay, taken on prescriber advice, does not erase weeks of treatment. What it does do is keep you safer while your body is fighting something else. If you want a fuller picture of how Mounjaro and flu interact and what that combination tends to look like in practice, our dedicated page covers it in detail. You can also read more about the broader picture of how Mounjaro works as a treatment and what it asks of your body week to week.

Dehydration: the practical risk to track closely

The MHRA's safety profile for GLP-1 receptor agonists highlights dehydration as a real concern when gastrointestinal illness coincides with treatment. The mechanism is straightforward: flu can cause fever, sweating, reduced oral intake, vomiting or loose stools, all of which deplete fluid volume. Mounjaro's own GI effects do not disappear just because you are unwell; if anything they may be more pronounced.

Signs of meaningful dehydration include a noticeably dry mouth, dark urine, dizziness on standing, and a significant drop in how much you are urinating. If any of these appear alongside severe or persistent vomiting, the NHS obesity treatment pathway would direct you to seek medical advice promptly rather than managing at home. This is not overcaution, kidney function can deteriorate quickly when fluid intake is severely compromised.

The same principle applies if flu has brought on diarrhoea: even without vomiting, prolonged loose stools while on tirzepatide can produce a deficit that catches people off guard. Oral rehydration rather than plain water is generally more effective; your prescriber or pharmacist can advise on suitable products.

Flu medicines alongside tirzepatide (what the guidance says

Most standard over-the-counter flu remedies) paracetamol-based products, antihistamines for congestion, saline nasal sprays, are not known to interact directly with tirzepatide in a way that changes the clinical picture materially. Paracetamol remains the standard first-choice analgesic and antipyretic and is generally considered appropriate alongside GLP-1 treatments.

Non-steroidal anti-inflammatory drugs (NSAIDs) such as ibuprofen are a different matter. They carry their own risk to kidney function and can irritate the stomach lining, both concerns that are heightened when you are already dehydrated or nauseated. NHS guidance routinely advises caution with NSAIDs during any acute illness involving dehydration risk, and that caution applies here too.

If you take other regular medications alongside Mounjaro (for blood pressure, blood sugar or other conditions) flu illness can affect how those are absorbed and tolerated as well. That is a reason to keep your prescriber informed rather than managing everything silently. For context on interactions more broadly, the GLP-1 interactions page covers the wider interaction landscape for tirzepatide. Patients who use hormone replacement therapy may also want to read our guidance on taking Mounjaro with HRT, and those managing irritable bowel syndrome can find condition-specific detail on taking Mounjaro with IBS.

When to pause, continue or call for help

There is no blanket rule that says stop Mounjaro the moment flu arrives. Mild flu with manageable symptoms, maintained fluid intake and no vomiting: many people continue without issue, and their prescriber would support that. But the calculation shifts if vomiting is persistent, if you cannot keep fluids down, or if your other health conditions are thrown off balance by the infection.

The MHRA's guidance for GLP-1 medicines advises patients to contact a healthcare professional if they experience severe or persistent gastrointestinal symptoms, that guidance does not carve out an exception for symptoms driven by flu rather than the medicine itself. The source matters less than the severity and duration. Our page on whether you can take Mounjaro when you have the flu walks through the key considerations to help you make that call with confidence.

Seek urgent medical attention if you develop severe, persistent abdominal pain that reaches toward your back, with or without vomiting. Acute pancreatitis is an infrequent but serious recognised risk with GLP-1 medicines, and flu-related abdominal discomfort should not automatically mask a symptom that needs proper evaluation. Report any suspected side effects at the MHRA Yellow Card scheme.

If you are already a patient through a regulated service and are unsure whether to take your next dose, contact your prescriber directly. For those exploring Mounjaro for the first time, our free consultation is the right starting point, a GPhC-registered prescriber reviews your health picture in full before any treatment begins. You can also check our frequently asked questions for practical guidance on day-to-day treatment, or get in touch with our aftercare team directly.